Day One Biopharmaceuticals Inc
Healthcare · USD
Price
$21.45
Cap
$2.2B
Earnings
3/4 beat
30d Trend
+0%
Near 52-week highs — limited upside before resistance
Target range: $17 – $21.5 (consensus: $20.86)
Consensus: Hold
Earnings history
Q4 2025
MISS
-0.21 vs -0.17
Q3 2025
BEAT
-0.19 vs -0.28
Q2 2025
BEAT
-0.29 vs -0.364
Q1 2025
BEAT
-0.35 vs -0.42
Key macro factors
Mergers and Acquisitions (M&A) in Biotechnology
Biopharmaceutical Regulatory Landscape (FDA/EMA)
Clinical Trial Data and Pipeline Development
Day One Biopharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing targeted therapies for people of all ages with life-threatening diseases, with a particular focus on pediatric cancer.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.